NCT02431767: Evaluating the Safety and Immunogenicity of PENNVAX®-GP DNA Vaccine and IL-12 Plasmid, Delivered Via Intradermal or Intramuscular Electroporation in Healthy, HIV-Uninfected Adults |
|
|
| Completed | 1 | 94 | US | PENNVAX®-GP HIV-1 DNA vaccine, Interleukin-12 (IL-12) DNA adjuvant, Placebo | National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections | 06/17 | 12/17 | | |
